Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Nucletron, an Elekta company, to Debut New Flexitron Brachytherapy Afterloading Platform at 2013 American Brachytherapy Society Meeting

April 18, 2013

Newly released brachytherapy delivery process features logical workflow and intuitive system operation for greater user and patient safety

NEW ORLEANS, April 18, 2013 /PRNewswire/ — At the 2013 American Brachytherapy Society (ABS) meeting April 18-20 in New Orleans, Nucletron, an Elekta company, (booth #300), will introduce its newly redesigned Flexitron® remote afterloading platform. Flexitron emphasizes safety and efficiency in the brachytherapy workflow, increasing the clinician’s confidence that execution of all workflow steps will proceed as planned for brachytherapy / treatment delivery.

Key to the new Flexitron are multiple advances that optimize the treatment delivery process. One of these features is an intuitive layout that efficiently leads the user through the treatment delivery workflow. Flexitron also includes transfer tubes that all are of the same 1000 mm length, reducing ambiguity; a “reference zero” at the entrance of the catheter; a dwell position number that directly reflects the dwell position distance; and forward stepping source positioning.

Flexitron features scalable configurations with 10, 20 or 40 channels and is compatible with Nucletron applicators, Oncentra® Brachy and the HDR Real-Time Prostate Solution.

“We are very pleased to introduce the new Flexitron afterloading platform to the North American market,” says Maurits Wolleswinkel, VP Business Line Management, for Elekta’s brachytherapy business area. “We believe Flexitron afterloading is revolutionizing safety and workflow in the modern brachytherapy practice, and since it is designed around an upgradable architecture, Flexitron represents a truly safe investment for the future.”

In addition to the newly released Flexitron, Elekta showcased the depth and breadth of its brachytherapy solutions, including Oncentra Brachy planning system, a fully developed line of body site specific applicators, and dedicated Real Time Prostate Solutions.

Learn more at: www.elekta.com/flexitron.

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.andersson@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta


Source: PR Newswire